174 related articles for article (PubMed ID: 28648552)
1. Epigenetic induction of melatonin MT
Bahna SG; Niles LP
Eur Neuropsychopharmacol; 2017 Aug; 27(8):828-832. PubMed ID: 28648552
[TBL] [Abstract][Full Text] [Related]
2. 5-Azacytidine upregulates melatonin MT
Hartung EE; Mukhtar SZ; Shah SM; Niles LP
Mol Biol Rep; 2020 Jun; 47(6):4867-4873. PubMed ID: 32410138
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic regulation of melatonin receptors in neuropsychiatric disorders.
Bahna SG; Niles LP
Br J Pharmacol; 2018 Aug; 175(16):3209-3219. PubMed ID: 28967098
[TBL] [Abstract][Full Text] [Related]
4. Clinically relevant concentrations of valproic acid modulate melatonin MT(1) receptor, HDAC and MeCP2 mRNA expression in C6 glioma cells.
Kim B; Rincón Castro LM; Jawed S; Niles LP
Eur J Pharmacol; 2008 Jul; 589(1-3):45-8. PubMed ID: 18550052
[TBL] [Abstract][Full Text] [Related]
5. Novel targets for valproic acid: up-regulation of melatonin receptors and neurotrophic factors in C6 glioma cells.
Castro LM; Gallant M; Niles LP
J Neurochem; 2005 Dec; 95(5):1227-36. PubMed ID: 16313512
[TBL] [Abstract][Full Text] [Related]
6. Endogenous alpha-synuclein is induced by valproic acid through histone deacetylase inhibition and participates in neuroprotection against glutamate-induced excitotoxicity.
Leng Y; Chuang DM
J Neurosci; 2006 Jul; 26(28):7502-12. PubMed ID: 16837598
[TBL] [Abstract][Full Text] [Related]
7. Regional upregulation of hippocampal melatonin MT2 receptors by valproic acid: therapeutic implications for Alzheimer's disease.
Bahna SG; Sathiyapalan A; Foster JA; Niles LP
Neurosci Lett; 2014 Jul; 576():84-7. PubMed ID: 24909617
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic targets for melatonin: induction of histone H3 hyperacetylation and gene expression in C17.2 neural stem cells.
Sharma R; Ottenhof T; Rzeczkowska PA; Niles LP
J Pineal Res; 2008 Oct; 45(3):277-84. PubMed ID: 18373554
[TBL] [Abstract][Full Text] [Related]
9. Human melatonin MT1 receptor induction by valproic acid and its effects in combination with melatonin on MCF-7 breast cancer cell proliferation.
Jawed S; Kim B; Ottenhof T; Brown GM; Werstiuk ES; Niles LP
Eur J Pharmacol; 2007 Mar; 560(1):17-22. PubMed ID: 17303109
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic mechanisms of melatonin action in human SH-SY5Y neuroblastoma cells.
Pan Y; Niles LP
Mol Cell Endocrinol; 2015 Feb; 402():57-63. PubMed ID: 25578604
[TBL] [Abstract][Full Text] [Related]
11. Valproic acid up-regulates melatonin MT1 and MT2 receptors and neurotrophic factors CDNF and MANF in the rat brain.
Niles LP; Sathiyapalan A; Bahna S; Kang NH; Pan Y
Int J Neuropsychopharmacol; 2012 Oct; 15(9):1343-50. PubMed ID: 22243807
[TBL] [Abstract][Full Text] [Related]
12. Additive effects of histone deacetylase inhibitors and amphetamine on histone H4 acetylation, cAMP responsive element binding protein phosphorylation and DeltaFosB expression in the striatum and locomotor sensitization in mice.
Shen HY; Kalda A; Yu L; Ferrara J; Zhu J; Chen JF
Neuroscience; 2008 Dec; 157(3):644-55. PubMed ID: 18848971
[TBL] [Abstract][Full Text] [Related]
13. Valproic acid exposure leads to upregulation and increased promoter histone acetylation of sepiapterin reductase in a serotonergic cell line.
Balasubramanian D; Deng AX; Doudney K; Hampton MB; Kennedy MA
Neuropharmacology; 2015 Dec; 99():79-88. PubMed ID: 26151765
[TBL] [Abstract][Full Text] [Related]
14. HDAC inhibition is associated to valproic acid induction of early megakaryocytic markers.
Vulcano F; Ciccarelli C; Mattia G; Marampon F; Giampiero M; Milazzo L; Pascuccio M; Zani BM; Giampaolo A; Hassan HJ
Exp Cell Res; 2006 May; 312(9):1590-7. PubMed ID: 16739251
[TBL] [Abstract][Full Text] [Related]
15. Valproate increases dopamine transporter expression through histone acetylation and enhanced promoter binding of Nurr1.
Green AL; Zhan L; Eid A; Zarbl H; Guo GL; Richardson JR
Neuropharmacology; 2017 Oct; 125():189-196. PubMed ID: 28743636
[TBL] [Abstract][Full Text] [Related]
16. Valproate promotes survival of retinal ganglion cells in a rat model of optic nerve crush.
Zhang ZZ; Gong YY; Shi YH; Zhang W; Qin XH; Wu XW
Neuroscience; 2012 Nov; 224():282-93. PubMed ID: 22867974
[TBL] [Abstract][Full Text] [Related]
17. Valproic acid induces functional heat-shock protein 70 via Class I histone deacetylase inhibition in cortical neurons: a potential role of Sp1 acetylation.
Marinova Z; Ren M; Wendland JR; Leng Y; Liang MH; Yasuda S; Leeds P; Chuang DM
J Neurochem; 2009 Nov; 111(4):976-87. PubMed ID: 19765194
[TBL] [Abstract][Full Text] [Related]
18. Targeting AML1/ETO-histone deacetylase repressor complex: a novel mechanism for valproic acid-mediated gene expression and cellular differentiation in AML1/ETO-positive acute myeloid leukemia cells.
Liu S; Klisovic RB; Vukosavljevic T; Yu J; Paschka P; Huynh L; Pang J; Neviani P; Liu Z; Blum W; Chan KK; Perrotti D; Marcucci G
J Pharmacol Exp Ther; 2007 Jun; 321(3):953-60. PubMed ID: 17389244
[TBL] [Abstract][Full Text] [Related]
19. Valproate-Induced Epigenetic Upregulation of Hypothalamic Fto Expression Potentially Linked with Weight Gain.
Zhang H; Lu P; Tang HL; Yan HJ; Jiang W; Shi H; Chen SY; Gao MM; Zeng XD; Long YS
Cell Mol Neurobiol; 2021 Aug; 41(6):1257-1269. PubMed ID: 32500354
[TBL] [Abstract][Full Text] [Related]
20. Induction of osteogenic differentiation of human mesenchymal stem cells by histone deacetylase inhibitors.
Cho HH; Park HT; Kim YJ; Bae YC; Suh KT; Jung JS
J Cell Biochem; 2005 Oct; 96(3):533-42. PubMed ID: 16088945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
